Hiroshige Yoshioka
Hiroshige Yoshioka publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #478,803 of 7,710,434 ranked researchers
- Rank in Japan
- #4,845 of 383,136
- Works
- 359
- Citations
- 17k
- Citations per work
- 48.5
What does Hiroshige Yoshioka research?
Hiroshige Yoshioka's work is mostly in Medicine (83%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences29882.9%
- Medicine29882.9%
- Everything else4211.8%
- Life Sciences195.3%
- 1Pulmonary and Respiratory Medicine45% of their works
- 2Oncology32% of their works
- 3Epidemiology3% of their works
- 4Molecular Biology3% of their works
- 5Radiology, Nuclear Medicine and Imaging2% of their works
- 6Cancer Research2% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cancer Treatment and Pharmacology
- Radiomics and Machine Learning in Medical Imaging
Which keywords describe Hiroshige Yoshioka's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles, Small-Cell Lung Cancer and CT Screening.
- Radiomics
- Taxanes
- Idiopathic Pulmonary Fibrosis
- KRAS Mutations
- Precision Medicine
- Immune Checkpoint Blockade
- CT Screening
- Genomic Profiles
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Small-Cell Lung Cancer
- Lung Cancer
- PD-1 and PD-L1
- Cetuximab
- Fibrosis
- Chemotherapy-Induced Peripheral Neuropathy
- Medical Imaging
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Clinical Trials3942 topics
- Targeted Therapy3942 topics
- Chemotherapy3333 topics
- ALK Inhibitors2501 topic
- EGFR Mutations2501 topic
- Genomic Profiles1441 topic
- Small-Cell Lung Cancer1441 topic
- CT Screening1411 topic
- Lung Cancer1411 topic
- Immune Checkpoint Blockade671 topic
- PD-1 and PD-L1671 topic
- Precision Medicine662 topics
- Cetuximab481 topic
- KRAS Mutations481 topic
- Fibrosis231 topic
- Idiopathic Pulmonary Fibrosis231 topic
- Chemotherapy-Induced Peripheral Neuropathy191 topic
- Taxanes191 topic
- Medical Imaging181 topic
- Radiomics181 topic
Where does Hiroshige Yoshioka work?
Hiroshige Yoshioka's main affiliation in the publication record is Kurashiki Central Hospital, Japan.
How many publications and citations does Hiroshige Yoshioka have?
OpenAlex counts 359 works and 17,407 citations for Hiroshige Yoshioka, an h-index of 51, ranking #478,803 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroshige Yoshioka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.